Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia

R. Bassan; O. Spinelli; E. Oldani; T. Intermesoli; M. Tosi; B. Peruta; E. Borlenghi; E. M. Pogliani; E. Di Bona; V. Cassibba; A. M. Scattolin; C. Romani; F. Ciceri; A. Cortelezzi; G. Gianfaldoni; D. Mattei; E. Audisio; A. Rambaldi

doi:10.1038/bcj.2014.48

Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia

R. Bassan, O. Spinelli, E. Oldani, T. Intermesoli, M. Tosi, B. Peruta, E. Borlenghi, E. M. Pogliani, E. Di Bona, V. Cassibba, A. M. Scattolin, C. Romani, F. Ciceri, A. Cortelezzi, G. Gianfaldoni, D. Mattei, E. Audisio, A. Rambaldi

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	e225
Journal	Blood Cancer Journal
Volume	4
Issue number	7
DOIs	https://doi.org/10.1038/bcj.2014.48
Publication status	Published - 2014

ASJC Scopus subject areas

Oncology
Hematology
Medicine(all)

Access to Document

10.1038/bcj.2014.48

Cite this

Bassan, R., Spinelli, O., Oldani, E., Intermesoli, T., Tosi, M., Peruta, B., Borlenghi, E., Pogliani, E. M., Di Bona, E., Cassibba, V., Scattolin, A. M., Romani, C., Ciceri, F., Cortelezzi, A., Gianfaldoni, G., Mattei, D., Audisio, E., & Rambaldi, A. (2014). Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia. Blood Cancer Journal, 4(7), [e225]. https://doi.org/10.1038/bcj.2014.48

Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia. / Bassan, R.; Spinelli, O.; Oldani, E.; Intermesoli, T.; Tosi, M.; Peruta, B.; Borlenghi, E.; Pogliani, E. M.; Di Bona, E.; Cassibba, V.; Scattolin, A. M.; Romani, C.; Ciceri, F.; Cortelezzi, A.; Gianfaldoni, G.; Mattei, D.; Audisio, E.; Rambaldi, A.

In: Blood Cancer Journal, Vol. 4, No. 7, e225, 2014.

Research output: Contribution to journal › Article › peer-review

Bassan, R, Spinelli, O, Oldani, E, Intermesoli, T, Tosi, M, Peruta, B, Borlenghi, E, Pogliani, EM, Di Bona, E, Cassibba, V, Scattolin, AM, Romani, C, Ciceri, F, Cortelezzi, A, Gianfaldoni, G, Mattei, D, Audisio, E & Rambaldi, A 2014, 'Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia', Blood Cancer Journal, vol. 4, no. 7, e225. https://doi.org/10.1038/bcj.2014.48

Bassan, R. ; Spinelli, O. ; Oldani, E. ; Intermesoli, T. ; Tosi, M. ; Peruta, B. ; Borlenghi, E. ; Pogliani, E. M. ; Di Bona, E. ; Cassibba, V. ; Scattolin, A. M. ; Romani, C. ; Ciceri, F. ; Cortelezzi, A. ; Gianfaldoni, G. ; Mattei, D. ; Audisio, E. ; Rambaldi, A. / Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia. In: Blood Cancer Journal. 2014 ; Vol. 4, No. 7.

@article{e9031431b4354a2ba8ca225d19e11dc1,

title = "Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia",

author = "R. Bassan and O. Spinelli and E. Oldani and T. Intermesoli and M. Tosi and B. Peruta and E. Borlenghi and Pogliani, {E. M.} and {Di Bona}, E. and V. Cassibba and Scattolin, {A. M.} and C. Romani and F. Ciceri and A. Cortelezzi and G. Gianfaldoni and D. Mattei and E. Audisio and A. Rambaldi",

year = "2014",

doi = "10.1038/bcj.2014.48",

language = "English",

volume = "4",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "7",

}

TY - JOUR

T1 - Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia

AU - Bassan, R.

AU - Spinelli, O.

AU - Oldani, E.

AU - Intermesoli, T.

AU - Tosi, M.

AU - Peruta, B.

AU - Borlenghi, E.

AU - Pogliani, E. M.

AU - Di Bona, E.

AU - Cassibba, V.

AU - Scattolin, A. M.

AU - Romani, C.

AU - Ciceri, F.

AU - Cortelezzi, A.

AU - Gianfaldoni, G.

AU - Mattei, D.

AU - Audisio, E.

AU - Rambaldi, A.

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84905377997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905377997&partnerID=8YFLogxK

U2 - 10.1038/bcj.2014.48

DO - 10.1038/bcj.2014.48

M3 - Article

C2 - 25014772

AN - SCOPUS:84905377997

VL - 4

JO - Blood Cancer Journal

JF - Blood Cancer Journal

SN - 2044-5385

IS - 7

M1 - e225

ER -

Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this